US Fertility

US Fertility operates as a partnership of physician-owned and physician-led fertility practices. Each partner practice retains its own equity and clinical decision-making authority. The central entity is not a traditional acquirer; instead, it provides practice-management, administrative, and laboratory services through its affiliated Ovation Fertility network, allowing physicians to focus on patient care and research.

The US Fertility Innovation Fund is an early-stage venture vehicle that deploys capital into companies the firm believes can improve access to fertility care and enhance pregnancy outcomes. The fund is inward-facing in the sense that it leverages the network’s clinical and laboratory infrastructure for deal sourcing and validation, per the firm’s website. Specific portfolio companies and fund size are not publicly disclosed.

Yes, US Fertility is affiliated with Ovation Fertility, a national network of premier IVF laboratories that operates alongside the partner practices. Together they manage 32 IVF laboratories, with a laboratory-management model designed to let clinical teams shift their focus from lab operations to direct patient care.

Because US Fertility both manages a national clinical network and houses a Research Division, it can test or co-develop products and technologies within its own partner practices. This operational backbone lets the Innovation Fund diligence opportunities against real-world clinical workflows, patient data, and physician feedback — a sourcing advantage that a pure financial investor would not have.

The firm states it is a physician-owned and physician-led partnership. It does not disclose any private equity ownership on its website. This is a structural differentiator from several competing consolidators in the fertility space that are backed by institutional PE capital.